Filing Details
Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material event.
8k filedNASDAQ:AFJK
Aimei Health Technology Co., Ltd. (AFJK) Reports Material Event to SEC
Filing Details Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material event. Market…
Market Context
Aimei Health Technology Co., Ltd.'s stock currently trades at $26.00 with a market capitalization of $197.8M. The Financial Services company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Aimei Health Technology Co., Ltd.'s stock.
All SEC filings for Aimei Health Technology Co., Ltd. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View AFJK Stock Page
Frequently Asked Questions
Where can I read AFJK's SEC filings?
Browse all filings on our AFJK SEC filings page.
What types of SEC filings does Aimei Health Technology Co., Ltd. file?
Public companies like Aimei Health Technology Co., Ltd. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.